MJARF - MJardin Group, Inc.
| Previous Close | 0.1000 |
| Open | 0.0710 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0710 - 0.1057 |
| 52 Week Range | 0.0500 - 2.6300 |
| Volume | 27,645 |
| Avg. Volume | 54,232 |
| Market Cap | 8.803M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1280 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.12 |
- GlobeNewswire
MJardin Receives Health Canada Approval for Amendment of Ontario Facility
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, announced today that one of its indoor cannabis cultivation facilities “WILL”, located in Brampton, Ontario has received licensed approval from Health Canada to its amendment application to significantly increase its current operational space and production supply to full facility capacity. The 32,800 square foot facility has received approval for eight additional grow areas and four additional operations areas which include grow, vegetative and mother rooms, as well as trim, dry, and packaging rooms. This amendment to its previous license for two rooms will allow WILL to produce its full capacity of 3,000 kg of dried flower and 900 kg of trim for a total of 3,900 kg.
- GlobeNewswire
MJardin Receives Cultivation and Processing License at Second Ontario Facility
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, announced today that one of its indoor cannabis cultivation facilities “GRO”, located in Dunnville, Ontario has received its cultivation and processing license from Health Canada. The facility is a joint venture between MJardin Group (75%) and Grand River Organics (25%). The 11,000 square foot facility is estimated to produce 1,200 kg of premium flower and 396 kg of trim for a total of 1,596 kg of product per year and is expected to reach full production capacity in Q3 2020.
- GlobeNewswire
MJardin Group Completes Non-Brokered Private Placement and Share Issuance to Robes Inc.
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, announced today the closing of a non-brokered private placement and share issuance of 4,716,982 common shares at a price of C$0.212 for an aggregate subscription amount of C$1,000,000. MJardin has previously announced that it will dedicate a portion of its cultivation canopy space to grow Robes’ exclusive strains as part of their November 2019 contract. MJardin will also use a portion of the proceeds to construct a packaging line at its “WILL” facility in Ontario in order to satisfy anticipated demand for packaged Cannabis products for retail distribution.
- GlobeNewswire
MJardin’s Atlantic Canada Cultivation & Extraction Facility Receives Sales Licence
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, is pleased to announce its AtlantiCann Medical Inc. (“AMI”) facility has been awarded a sales licence from Health Canada. AMI is a joint venture corporation consisting of Nova Scotia Mi’kmaq First Nations (51%), MJardin Group, Inc. (39%) and the Halef Group (10%). The licence comes just weeks before phase 2 construction is set to be complete adding 20,000 square feet to the original footprint making the expanded facility 68,000 square feet with a total of 6,300 kg/year of production capacity.
- Benzinga
Harvest Health Weighs $87.5M Purchase Of Cannabis Retailer Have A Heart
Harvest Health & Recreation Inc (CSE: HARV) (OTC: HRVSF ), a vertically integrated cannabis company, said Monday that it is in negotiations to acquire Interurban Capital Group Inc, the owner and operator ...
- Benzinga
Harvest Health & Recreation Buys Nevada Grow Facility From MJardin Group In $35M Deal
Multistate operator Harvest Health & Recreation Inc (OTC: HRVSF ) said Thursday that it has agreed to purchase a 32,000-square-foot subruban Las Vegas cultivation facility from the Cheyenne, Nevada-based ...
- GlobeNewswire
MJardin Enters into Definitive Agreement for the Sale of its Cheyenne Cultivation Facility
MJardin Group, Inc. (“MJardin” or the “Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, announced today that it has entered into a definitive agreement with Harvest DCP of Nevada, Cheyenne Holdings LLC, a division of Harvest Health and Recreation Inc. (HARV.CN) to sell all of its interest in GreenMart of Nevada LLC, which possesses a Nevada Marijuana Cultivation Facility License and operates the cultivation facility at 5421 E. Cheyenne, Nevada, (“Cheyenne”) for a total consideration of US$35 million in cash, comprised of US$30 million on December 31, 2019, plus US$5 million upon license transfer (the “Transaction”), subject to regulatory approvals.
- Benzinga
MJardin Receives Cultivation, Processing License For Warman Facility
MJardin Group Inc (CSE: MJAR) (OTC: MJARF) said Monday that it received a Health Canada cultivation and processing license for Warman, a 120,000-square-foot facility in Winnipeg, Manitoba and the largest in the company's portfolio. “This is a great milestone for our flagship facility in Winnipeg and a great day for the team,” CEO Pat Witcher said in a statement. A hybrid facility with both indoor and greenhouse production capability is planned, with certified extraction, processing and packaging capabilities.
- GlobeNewswire
MJardin Awarded Cultivation & Processing License from Health Canada for its Largest Facility
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, announced today that it has received its cultivation and processing license from Health Canada for “Warman”, a 120,000 sq. ft. retro-fitted cultivation facility located in Winnipeg, Manitoba, the largest in the Company’s portfolio. “This is a great milestone for our flagship facility in Winnipeg and a great day for the team,” said Pat Witcher, Chief Executive Officer of MJardin Group.
- Benzinga
MJardin Reports Q3 Earnings
Cannabis management platform MJardin Group, Inc. (CSE:MJAR) (OTC: MJARF ) reported Monday third-quarter revenue of CA$7.6 million, down from CA$9.2 million in the same period of 2019. The company achieved ...
- GlobeNewswire
MJardin Group Announces Third Quarter 2019 Financial Results
DENVER and TORONTO, Nov. 25, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced its.
- GlobeNewswire
MJardin Group Inc. Appoints Patrick Witcher as Chief Executive Officer
MJardin Group, Inc. (“MJardin” or the “Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, announced today the appointment of Mr. Patrick Witcher as Chief Executive Officer of the Company. Mr. Witcher held the role of MJardin’s Chief Operations Officer for the past year following his term as President, Global Operations. Prior to joining the MJardin family, Mr. Witcher was President and Chief Compliance Officer of Buddy Boy Brands, a cultivation and retail/medical dispensary group located in Denver, Colorado.
- Simply Wall St.
Could MJardin Group, Inc.'s (CNSX:MJAR) Investor Composition Influence The Stock Price?
If you want to know who really controls MJardin Group, Inc. (CNSX:MJAR), then you'll have to look at the makeup of its...
- GlobeNewswire
MJardin Group Inc. Announces Partnership with Robes Inc. to Cultivate and Distribute Robes Cannabis and BLLRDR Brands
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, is pleased to announce that it has entered into a partnership with Robes Inc. (“Robes”), a luxury cannabis brand house focused on bringing exotic and rare strains to Canadian consumers. Under the partnership agreement, MJardin will cultivate specific unique strains as selected by Robes, for the Canadian market. Robes Inc. is a privately held company founded by its CEO, Max Zavet and President, Lorne Greenberg.
- GlobeNewswire
MJardin Group to Issue Third Quarter 2019 Financial Results & Conference Call November 25, 2019
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), is pleased to announce that it will report its third quarter 2019 financial results for the period ended September 30, 2019, before market open on November 25, 2019. The Company will host a conference call on the same day at 10:00 am ET. The senior management team will discuss the Company’s financial performance for the period ended September 30, 2019.
- GlobeNewswire
MJardin Group Provides Update on Cannabella Acquisition
The Common Shares are being priced at $0.715 CAD per Common Share and will reduce the purchase price payable on closing of the Cannabella acquisition by $400,000 USD. The $3.6 million USD balance of the purchase price will be payable in Common Shares upon closing, with the pricing of such Common Shares based on the trading price of MJardin shares at the time of closing.
- GlobeNewswire
MJardin Group Inc. Announces new Chief Financial Officer
MJardin Group, Inc. (“MJardin” or the “Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, announced today the appointment of Mr. Edward Jonasson, MBA, CPA, CA, CPA (IL) as Chief Financial Officer of the Company, effective November 1, 2019. Mr. Jonasson brings to the Company more than 25 years of business experience in public and private accounting. Prior to joining MJardin, Mr. Jonasson was Vice President Finance and Group Corporate Controller at The Stars Group Inc. Mr. Jonasson also held senior finance positions at Open Text Corporation and DWL Incorporated.
- GlobeNewswire
MJardin Receives Full Purchase Price from Joint Venture Partner and Begins Phase 2 Development at its Largest Cultivation Facility
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, announced today that subsequent to its recently announced non-binding Letter of Intent (“LOI”) with Peguis First Nation (“Peguis”) in connection with its Warman cultivation facility located in Winnipeg, Manitoba, the Company has entered into an agreement whereby Peguis has agreed to pay the full amount of the purchase price in advance of the closing of the transaction pursuant to a promissory note. MJardin has received the C$11 million payment from Peguis, which immediately allows the Company to commence Phase 2 construction and expedite the path to full production of the Warman facility. On August 28, 2019, MJardin announced the signing of a non-binding LOI with Peguis concerning a joint venture (“JV”) in connection with the operation and ownership of its Warman cultivation facility.
- GlobeNewswire
MJardin to Present at Canaccord Genuity 2nd Annual U.S. Cannabis Symposium
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, announced today that the Company will present at the Canaccord Genuity 2nd Annual U.S. Cannabis Symposium. Patrick Witcher, Chief Operating Officer, will present on the Company’s growth strategy and will be joined by Board member and Company Founder, James Lowe, to meet with investors. The formal presentation is scheduled for 11:50 am ET on Thursday, October 3rd, 2019 at the Sheraton Centre Toronto Hotel and can be found on the Company’s website at http://investors.mjardin.com/Investor-Presentations.
- GlobeNewswire
Franchise Cannabis’s German Subsidiary ACA Müller Commits to Purchase of Medical Cannabis from MJardin’s Halifax Facility Due to Rapid Growth in German Patient Demand
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, announces a supply contract with ACA Müller ADAG Pharma Vertriebs GmbH (“ACA Müller”), a subsidiary of Franchise Cannabis Corp. (“Franchise”), for the supply offtake of a total of 2,250 kg of medical cannabis over a nine month period in 2020 from MJardin’s 48,000 square foot Halifax facility (“AMI”)*. ACA Müller has committed to purchase 250 kgs a month of high THC (>20%) medical cannabis flower during Q1 to Q3 2020 at a set price throughout the year.
- GlobeNewswire
MJardin Group Announces Second Quarter 2019 Financial Results and Conference Call
DENVER and TORONTO, Aug. 29, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced its.
- GlobeNewswire
MJardin Group Announces Design Finalization and Signing of Non-Binding Warman Letter of Intent
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, today announced it has finalized the design for its Warman Road project in Winnipeg, Manitoba (“Warman”), a hybrid facility encompassing indoor and greenhouse production along with full EU GMP certified extraction, processing and packaging capabilities. The Company also announced the signing of a non-binding Letter of Intent (“LOI”) with Peguis First Nation (“Peguis”) for a Joint Venture (“JV”) in connection with the operation and ownership of Warman.
- GlobeNewswire
MJardin Announces Phase 1 Construction Completion of their Manitoba Cultivation Facility, Submits Evidence of Readiness Package to Health Canada
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, announced today that it has submitted its Evidence of Readiness package to Health Canada and completed construction on Phase 1 of “WARMAN”, a retrofitted indoor cultivation facility located in Winnipeg, Manitoba and the largest in the Company’s portfolio. “Reaching this Health Canada milestone at our flagship Winnipeg facility is a significant achievement for our company,” noted Eric Gattoni, SVP, Operations of MJardin Group. “We look forward to cultivation at this facility as well as releasing our plans for Phase 2 of the project.” “WARMAN” is MJardin’s fourth Canadian cannabis cultivation facility to submit an Evidence of Readiness package to Health Canada.
- GlobeNewswire
RAMA First Nation and MJardin Group Release Designs for Combination Indoor/Greenhouse Cannabis Campus
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, today released, with its joint-venture partner the Chippewas of Rama First Nation (51%), designs of their 94,650 sq. ft. cannabis campus to be located in the community of Rama, Ontario. The campus will be a combination of indoor/greenhouse cultivation with interior space of 62,400 sq. ft containing six cultivation rooms for production of high-end flower, all necessary cultivation support spaces, a 5,500 sq. ft GMP certified extraction facility, a cannabis education centre and a retail dispensary. “We are thrilled with this design and what it will mean to our community.
- GlobeNewswire
MJardin Group Receives Transfer of License Agreement Resulting in Full Ownership Status of Nevada Cultivation Facility
MJardin Group, Inc. (“MJardin” or “the Company”) (MJAR.CN) (MJARF), a leader in premium cannabis production, today announced it has successfully closed and received the ownership transfer of license for its Cheyenne Ave., Las Vegas, Nevada cultivation facility (the “Facility”) from GreenMart of Nevada, LLC (“GreenMart”), providing the Company with its first 100% owned and operated cultivation facility in Nevada. As a result of this transaction MJardin now owns the license to cultivate medical and recreational cannabis at its Las Vegas facility.
